GlassScriptPhysician profile
Troy A Tada
NPI 1407114713
$17,853.45
in general payments reported to CMS, 2019-2025
45 companies · $2,068 in 2025
The $2,068 reported for 2025 was more than what 83% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,174 · 2020: $1,972 · 2021: $3,254 · 2022: $2,001 · 2023: $1,862 · 2024: $1,523 · 2025: $2,068.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,787 · Travel and Lodging: $666.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,786.76 |
| Travel and Lodging | $665.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,948.96 | 2019-2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $1,867.88 | 2019-2025 | General - Pain Management |
| Medtronic, INC. | $1,548.08 | 2021-2025 | Intellis Adaptivestim, Plasmablade(Tm), Aquamantys(Tm) |
| Medtronic USA, INC. | $1,521.65 | 2019-2020 | |
| Vertiflex, INC. | $1,344.69 | 2019 | |
| Nevro Corp. | $1,015.29 | 2019-2024 | Senza |
| Abbvie INC. | $882.66 | 2021-2025 | Qulipta, Ubrelvy |
| Stryker Corporation | $784.49 | 2021-2025 | Mild Device Kit, Optablate, Spinejack |
| Spinal Simplicity, LLC | $752.02 | 2022-2023 | Ha Minuteman G3-R |
| Pfizer INC. | $399.04 | 2019-2023 | |
| Biotronik Nro, INC. | $362.18 | 2023-2025 | Prospera, Biotronik |
| Arbor Pharmaceuticals, INC. | $290.98 | 2019-2021 | |
| Eisai INC. | $271.59 | 2020-2021 | |
| Avanos Medical | $271.42 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $255.74 | 2019-2023 | Trintellix |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $201.07 | 2019-2021 | |
| Si-Bone, INC. | $180.32 | 2019-2025 | |
| Tersera Therapeutics LLC | $178.15 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $153.85 | 2025 | |
| Allergan, INC. | $152.85 | 2019-2021 | |
| Painteq LLC | $133.15 | 2023 | Painteq |
| Nuvasive, INC. | $114.15 | 2021 | |
| Ibsa Pharma INC. | $109.90 | 2020-2023 | Tirosint, Licart |
| Radius Health, INC. | $108.63 | 2019-2021 | |
| Daiichi Sankyo INC. | $105.14 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $88.03 | 2022 | |
| Mml US, INC. | $87.33 | 2023-2025 | Reactiv8 |
| Galt Pharmaceuticals, LLC | $86.56 | 2023 | Orphengesic Forte |
| Biohaven Pharmaceuticals, INC. | $77.31 | 2021 | |
| Amgen INC. | $59.76 | 2021-2025 | Evenity |
| Curonix LLC | $54.97 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pacira Pharmaceuticals Incorporated | $53.39 | 2021-2023 | Iovera, Zilretta, Exparel |
| Merz Pharmaceuticals, LLC | $47.96 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $43.37 | 2021 | |
| Hydrocision, INC. | $41.21 | 2024 | Tenjet |
| Scilex Pharmaceuticals INC. | $40.03 | 2019-2023 | Ztlido |
| Merck Sharp & Dohme LLC | $38.22 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.36 | 2021-2025 | Relistor |
| Merz North America, INC. | $28.40 | 2019 | |
| Orthofix Medical, INC. | $24.96 | 2023 | Spinal-Stim, Cervical-Stim |
| Lilly USA, LLC | $24.18 | 2019 | |
| Dilon Technologies, INC. | $21.37 | 2025 | Hemoblast Bellows |
| Biodelivery Sciences International, INC. | $18.82 | 2020 | |
| Piramal Critical Care | $17.89 | 2022 | |
| Pacira Therapeutics, INC. | $14.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy Tada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.